MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

L Zhang, Y Liao, L Tang - Journal of Experimental & Clinical Cancer …, 2019 - Springer
Abstract MicroRNA-34 (miR-34) has been reported to be dysregulated in various human
cancers and regarded as a tumor suppressive microRNA because of its synergistic effect …

Research progress of aging-related microRNAs

Z Chen, C Li, H Huang, YL Shi… - Current Stem Cell …, 2024 - ingentaconnect.com
Senescence refers to the irreversible state in which cells enter cell cycle arrest due to
internal or external stimuli. The accumulation of senescent cells can lead to many age …

Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis

X Guo, Q Zhou, D Su, Y Luo, Z Fu, L Huang, Z Li… - Molecular cancer, 2020 - Springer
Background Accumulating evidence suggests that circular RNAs (circRNAs) are important
participants in cancer progression. However, the biological processes and underlying …

Identification of ITPR1 gene as a novel target for hsa-miR-34b-5p in non-obstructive azoospermia: a Ca2+/apoptosis pathway cross-talk

B Maleki, P Modarres, P Salehi, S Vallian - Scientific Reports, 2023 - nature.com
Abstract MiR-34b-5p has been reported as a non-invasive diagnostic biomarker for infertility.
However, no gene targets regulating the mechanism of cation of this miRNA are known. In …

Mesenchymal stem cell-derived extracellular vesicles transmitting microRNA-34a-5p suppress tumorigenesis of colorectal cancer through c-MYC/DNMT3a/PTEN axis

J Zhao, H Lin, K Huang - Molecular neurobiology, 2022 - Springer
Mesenchymal stem cell–derived extracellular vesicles (MSC-EV) can transport microRNAs
(miRNAs) into colorectal cancer (CRC) cells, thus to inhibit the malignant phenotype of …

Mechanism of SUMOylation-mediated regulation of type I IFN expression

L Du, W Liu, ST Rosen, Y Chen - Journal of Molecular Biology, 2023 - Elsevier
Type I interferons (IFN) are cytokines that bridge the innate and adaptive immune response,
and thus play central roles in human health, including vaccine efficacy, immune response to …

SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma

L Du, W Liu, G Aldana-Masangkay, A Pozhitkov… - Journal of Experimental …, 2022 - Springer
Background Multiple myeloma (MM) is an incurable plasma cell malignancy. Although
Dexamethasone (Dex) is the most widely used therapeutic drug in MM treatment, patients …

Allosteric inhibition of ubiquitin-like modifications by a class of inhibitor of SUMO-activating enzyme

YJ Li, L Du, J Wang, R Vega, TD Lee, Y Miao… - Cell chemical …, 2019 - cell.com
Summary Ubiquitin-like (Ubl) post-translational modifications are potential targets for
therapeutics. However, the only known mechanism for inhibiting a Ubl-activating enzyme is …

Targeting SUMOylation in cancer

L Du, W Liu, ST Rosen - Current opinion in oncology, 2021 - journals.lww.com
SUMOylation plays an important role in tumor EMT, metastasis, therapy resistance, and
antitumor immune response. Pharmaceutical inhibition of SUMOylation has become …

Regulation of DNA damage response and homologous recombination repair by microRNA in human cells exposed to ionizing radiation

M Szatkowska, R Krupa - Cancers, 2020 - mdpi.com
Ionizing radiation may be of both artificial and natural origin and causes cellular damage in
living organisms. Radioactive isotopes have been used significantly in cancer therapy for …